This month the BMJ has published a trial on the use of convalescent plasma in the treatment of admitted patients with COVID-19 (the PLACID trial). Convalescent plasma therapy basically takes plasma, together with antibodies from patients who have recovered from …
The UK Trainee Emergency Research Network (TERN) was created (officially) in 2018 and mentioned previously by Simon & Dan in this early digital outing. The initial mission was to demystify clinical research, improve access to research opportunities, and produce practice-changing evidence. …
Back in 2013, I wrote a post here on petechiae in well kids; it received a phenomenal number of views for reasons I don’t quite understand (I think it ended up as a link somewhere significant) and for a while …
I’m not sure whether you have noticed, but the first two episodes of the CODA Zero program are now live on their website. If you did not already know, the CODA project is designed to engage the #FOAMed communities across …
Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed newer direct oral anticoagulant treatments …
Welcome to our audio round up of everything on the blog during September. It’s been a relatively quiet on the blog post this month, but we chat through not only blogposts on the REMAP-CAP trial, …
That’s a leading question. Of course you would. Who wouldn’t want to know more about a disease that has killed >1 million people to date, worldwide. Who wouldn’t want to know more about the thromboembolic risk associated …
We previously covered the RECOVERY trial press release on the use of HCQ for hospitalised patients with COVID19. This is a UK based platform trial (more on this later) looking at patients admitted to hospital …
Appendicitis is a common problem in the emergency department, and for many years the standard of care has been to perform surgery to resolve it. When I trained in surgery (before transferring to EM) this …
This week I am joining the iMED conference 12.0 in Lisbon, Portugal, except I’m not really as I am in my office here in Manchester as a result of the COVID19 pandemic. Lisbon is a …
Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also be using it in mild/moderate …
This week I should be on my way to Australia for the CODA Change conference. For obvious reasons I am not going and am sat at home in Manchester enjoying the last remnants of the …
Has your department been relying on clinical gestalt to risk stratify patients, perhaps using something you heard or read about in a short paper (perhaps Twitter), maybe something like post-exertional oxygenation has caught your eye, …
Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence was not entirely definitive, but …
